Accugenomics, Inc. - Product Pipeline Analysis, 2013 Update - New Report Available
AccuGenomics, Inc. (AccuGenomics) is a diagnostic company. The company provides gene expression tests which diagnose, monitor and inform cancer treatment. It concentrates on developing standardized molecular diagnostic tests utilizing its patented technology in the field of oncology. AccuGenomics' diagnostic tests include standardized BCR-ABL molecular diagnostics test, lung cancer risk test, and additional tests. The company's proprietary molecular diagnostics tests, the proprietary combination of internal standards offer standardized, quantitative, numerical measurements which enables gene expression based molecular diagnostics tests to be...
View full press release